Search Results - "Baillod, A."

Refine Results
  1. 1

    Atrial thrombus and central venous dialysis catheters by Kingdon, Edward J., Holt, Stephen G., Davar, Joseph, Pennell, Dudley, Baillod, Rosemarie A., Burns, Aine, Sweny, Paul, Davenport, Andrew

    Published in American journal of kidney diseases (01-09-2001)
    “…A native arteriovenous fistula is the first choice for hemodialysis access. Despite improved catheter designs and the use of internal jugular veins, thrombotic…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Home dialysis: Lessons in patient education by Baillod, Rosemarie A.

    Published in Patient education and counseling (01-09-1995)
    “…The concept of home haemodialysis for the regular treatment of renal failure was first put into practice in 1964, 30 years ago. It proved extremely successful…”
    Get full text
    Journal Article
  4. 4

    Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1-alpha hydroxycholecalciferol supplementation by Ali, A A, Varghese, Z, Moorhead, J F, Baillod, R A, Sweny, P

    Published in Clinical nephrology (01-04-1993)
    “…Calcium set point was measured in 12 patients on chronic hemodialysis. Dialysate calcium concentration was 1.65 mmol/l. Calcium carbonate (CaCO3) was used as…”
    Get more information
    Journal Article
  5. 5

    Apolipoprotein B turnover in dialysis patients: its relationship to pathogenesis of hyperlipidemia by Chan, P C, Persaud, J, Varghese, Z, Kingstone, D, Baillod, R A, Moorhead, J F

    Published in Clinical nephrology (01-02-1989)
    “…Exogenously labelled Iodine-125-VLDL (very low density lipoprotein) was given intravenously to twelve dialysis patients and four normal controls. Specific…”
    Get more information
    Journal Article
  6. 6

    Integrating Novel Stellarator Single-Stage Optimization Algorithms to Design the Columbia Stellarator Experiment by Baillod, A, Paul, E. J, Rawlinson, G, Haque, M, Freiberger, S. W, Thapa, S

    Published 08-09-2024
    “…The Columbia Stellarator eXperiment (CSX), currently being designed at Columbia University, aims to test theoretical predictions related to QA plasma behavior,…”
    Get full text
    Journal Article
  7. 7

    Stellarator optimization for nested magnetic surfaces at finite $\beta$ and toroidal current by Baillod, A, Loizu, J, Graves, J. P, Landreman, M

    Published 30-11-2021
    “…Physics of Plasmas 29, 042505 (2022) Good magnetic surfaces, as opposed to magnetic islands and chaotic field lines, are generally desirable for stellarators…”
    Get full text
    Journal Article
  8. 8

    Equilibrium $\beta$-limits dependence on bootstrap current in classical stellarators by Baillod, A, Loizu, J, Qu, Z, Arbez, H. P, Graves, J. P

    Published 23-11-2022
    “…While it is important to design stellarators with high magneto-hydrodynamic (MHD) stability $\beta$-limit, it is also crucial to ensure that good magnetic…”
    Get full text
    Journal Article
  9. 9

    Musculoskeletal manifestations of amyloidosis : a review of 83 patients on haemodialysis for at least 10 years by KURER, M. H. J, BAILLOD, R. A, MADGIWCK, J. C. A

    “…Long-term regular haemodialysis for chronic renal failure is associated with amyloidosis. In this condition excess amounts of the unexcretable plasma protein…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysis by Neville, L O, Baillod, R A, Brumfitt, W, Hamilton-Miller, J M

    Published in Journal of antimicrobial chemotherapy (01-01-1988)
    “…Twelve cases of peritonitis caused by Gram-positive bacteria in 11 dialysis patients were treated with teicoplanin. Treatment, which was continued for three…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Vitamin A toxicity and hypercalcaemia in chronic renal failure by Farrington, K, Miller, P, Varghese, Z, Baillod, R A, Moorhead, J F

    “…Serum vitamin A concentrations were measured in 38 patients undergoing haemodialysis, 24 of whom were taking multivitamin preparations containing vitamin A…”
    Get full text
    Journal Article
  14. 14

    Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one by Kontoghiorghes, G J, Barr, J, Baillod, R A

    Published in Arzneimittel-Forschung (01-04-1994)
    “…The oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1, deferiprone, CAS 30652-11-0) has been tested in 11 renal dialysis patients, 10 for aluminium and 1 for…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    Cefuroxime pharmacokinetics in continuous and intermittent peritoneal dialysis by Chan, M K, Browning, A K, Poole, C J, Matheson, L A, Li, C S, Baillod, R A, Moorhead, J F

    Published in Nephron (2015) (01-01-1985)
    “…Pharmacokinetics of cefuroxime was studied in patients on continuous ambulatory or intermittent peritoneal dialysis. A single intravenous bolus (15 mg/kg) of…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Plasma Renin Activity and Blood Pressure in 89 Patients Receiving Maintenance Haemodialysis Therapy by Craswell, P. W., Hird, V. M., Judd, P. A., Baillod, R. A., Varghese, Z., Moorhead, J. F.

    Published in British Medical Journal (30-12-1972)
    “…Blood pressure, plasma renin activity, plasma sodium concentration, plasma potassium concentration, dietary sodium intake, and duration of dialysis have been…”
    Get full text
    Journal Article
  20. 20